Co-Diagnostics to Hold Press Conference
Co-Diagnostics, Inc. (Nasdaq: CODX) will hold a press conference on September 16 at 10:30 a.m. ET. The event is open to media, analysts, and investors.
Molecular diagnostics company Co-Diagnostics, Inc. (Nasdaq: CODX) announced it will host a press conference on September 16, commencing at 10:30 a.m. Eastern Time (ET). The conference will be accessible to members of the media, analysts, and investors, both in person and via a live webcast.
The purpose of the press conference is to provide an update on the company's current operations and strategic direction. Co-Diagnostics utilizes a patented platform for molecular diagnostics, and the event is expected to cover details regarding its applications and market potential.
The company has previously introduced various products and technologies aimed at enhancing the accessibility and efficiency of diagnostic testing. Further specifics regarding the agenda for the press conference will be disclosed closer to the date.
This event offers stakeholders an opportunity for direct engagement with the company's management and to pose questions. The hosting of this conference signifies Co-Diagnostics' commitment to transparent communication and maintaining stakeholder relations.